Maximizing your child's potential through genetic screening.
Splendor helps nonprofits find and win grants.
Fortuna Genomics employs methods from revolutionary genomics studies to non-invasively assess embryo traits, enabling parents to optimize their children's innate qualities without the need for gene editing. Through comprehensive genetic screening and forecasting, it empowers families to make informed decisions, optimizing their child’s well-being and capabilities from conception. With the convergence of advancements in genomic technologies, association studies, and sequencing efficiency, we are at a unique inflection point where such services can become widely accessible and impactful. Accurately predicting complex traits from genetic markers involves sophisticated models that must account for the interplay between countless biological and statistical factors. Our team is well-equipped to tackle this problem and make every parent's dream a reality by allowing them to give their children the best possible start in life.
Powered by thousands of successful proposals, Splendor's AI platform helps nonprofits write winning grant narratives and find the best funders. Our proposals capture every funder priority and maximize success rates.
This is a full pivot: the company changed from embryo genetic screening for parents (fertility/genomics) to AI-driven grant-writing for nonprofits. Completely different product, target market, and problem domain.